| Year |
Citation |
Score |
| 2020 |
Wang Y, Nanda V, Direnzo D, Ye J, Xiao S, Kojima Y, Howe KL, Jarr KU, Flores AM, Tsantilas P, Tsao N, Rao A, Newman AAC, Eberhard AV, Priest JR, et al. Clonally expanding smooth muscle cells promote atherosclerosis by escaping efferocytosis and activating the complement cascade. Proceedings of the National Academy of Sciences of the United States of America. PMID 32541024 DOI: 10.1073/Pnas.2006348117 |
0.316 |
|
| 2020 |
Le TM, Udyavar A, Kim W, Cho AE, Li L, DiRenzo D, Rosen B, Walters MJ, Tan JBL, Radu CG. Abstract A46: CD73 inhibition enhances the effect of anti-PD-1 therapy on KRAS-mutated pancreatic cancer model Cancer Immunology Research. 8. DOI: 10.1158/2326-6074.Tumimm19-A46 |
0.362 |
|
| 2019 |
DiRenzo D, Ashok D, Anderson AE, Udyavar A, Tan JB, Luu IM, Zhang K, Jeffrey JL, Seitz L, Leleti MR, Young SW, Powers JP, Walters MJ. Abstract 3168: Methods for assessment of the “adenosine fingerprint” in clinical trials of AB928 Cancer Research. 79: 3168-3168. DOI: 10.1158/1538-7445.Sabcs18-3168 |
0.357 |
|
| 2019 |
Anderson AE, DiRenzo D, Lee S, Udyavar A, Gerrick K, Singh H, Zhao X, Jin L, Seitz L, Walker NP, Walters MJ, Tan JB. Abstract 1557: Characterization of AB154, a humanized anti-TIGIT antibody, for use in combination studies Cancer Research. 79: 1557-1557. DOI: 10.1158/1538-7445.Sabcs18-1557 |
0.429 |
|
| 2019 |
Udyavar AR, DiRenzo D, Ashok D, Anderson AE, Young SW, Walters MJ, Tan JB. Abstract 4980: Altered pan-Ras pathway and activating mutations in EGFR result in elevated CD73 in multiple cancers Cancer Research. 79: 4980-4980. DOI: 10.1158/1538-7445.Am2019-4980 |
0.368 |
|
| 2018 |
Becker A, Narasappa N, Yin F, Zhang K, DiRenzo D, Park T, Kalisiak J, Lawson K, Jeffrey J, Powers JP, Schindler U, Walters MJ, Tan JB. Abstract 710: CD73 inhibitors (CD73i) reverse the AMP/adenosine-mediated impairment of immune effector cell activation by immune checkpoint inhibitors (ICI) Cancer Research. 78: 710-710. DOI: 10.1158/1538-7445.Am2018-710 |
0.389 |
|
| 2018 |
Walters MJ, Piovesan D, Tan J, DiRenzo D, Yin F, Miles D, Leleti MR, Park T, Soriano F, Sharif E, Schindler U, Powers JP. Abstract 5556: Combining adenosine receptor inhibition with AB928 and chemotherapy results in greater immune activation and tumor control Cancer Research. 78: 5556-5556. DOI: 10.1158/1538-7445.Am2018-5556 |
0.366 |
|
| 2017 |
DiRenzo D, Owens GK, Leeper NJ. "Attack of the Clones": Commonalities Between Cancer and Atherosclerosis. Circulation Research. 120: 624-626. PMID 28209794 DOI: 10.1161/Circresaha.116.310091 |
0.391 |
|
| 2016 |
Jiang M, Azevedo-Pouly A, Deering TG, Hoang CQ, DiRenzo D, Hess DA, Konieczny SF, Swift GH, MacDonald RJ. MIST1 and PTF1 Collaborate in Feed-forward Regulatory Loops that Maintain the Pancreatic Acinar Phenotype in Adult Mice. Molecular and Cellular Biology. PMID 27644326 DOI: 10.1128/Mcb.00370-16 |
0.689 |
|
| 2015 |
Pyronnet S, Lasfargues C, Martineau Y, Müller D, Hess DA, DiRenzo D, Khoutorsky A, Baer R, Guillermet-Guibert J, Sonenberg N, Konieczny SF, Bousquet C. Translational regulation of exocrine cell function and survival by ATF4-dependent expression of 4E-BP1 Pancreatology. 15: S48. DOI: 10.1016/J.Pan.2015.05.196 |
0.662 |
|
| 2013 |
Shi G, DiRenzo D, Qu C, Barney D, Miley D, Konieczny SF. Maintenance of acinar cell organization is critical to preventing Kras-induced acinar-ductal metaplasia. Oncogene. 32: 1950-8. PMID 22665051 DOI: 10.1038/Onc.2012.210 |
0.715 |
|
| 2012 |
Direnzo D, Hess DA, Damsz B, Hallett JE, Marshall B, Goswami C, Liu Y, Deering T, Macdonald RJ, Konieczny SF. Induced Mist1 expression promotes remodeling of mouse pancreatic acinar cells. Gastroenterology. 143: 469-80. PMID 22510200 DOI: 10.1053/J.Gastro.2012.04.011 |
0.715 |
|
| 2011 |
Coon BG, Direnzo DM, Konieczny SF, Aguilar RC. Epsins' novel role in cancer cell invasion. Communicative & Integrative Biology. 4: 95-7. PMID 21509192 DOI: 10.4161/Cib.14129 |
0.642 |
|
| 2010 |
Garside VC, Kowalik AS, Johnson CL, DiRenzo D, Konieczny SF, Pin CL. MIST1 regulates the pancreatic acinar cell expression of Atp2c2, the gene encoding secretory pathway calcium ATPase 2. Experimental Cell Research. 316: 2859-70. PMID 20599950 DOI: 10.1016/J.Yexcr.2010.06.014 |
0.677 |
|
| 2009 |
DiRenzo D, Shi G, Konieczny SF. Abstract A76: A novelin vivomodel for pancreatic restructuring and suppression of transformation Cancer Research. 69. DOI: 10.1158/0008-5472.Fbcr09-A76 |
0.715 |
|
| 2009 |
Shi G, DiRenzo D, Konieczny SF. Abstract A71: Distinct functions of epithelial growth factor receptor (EGFR) pathways in pancreatic acinar cell differentiation and initiation of pancreatic ductal adenocarcinoma Cancer Research. 69. DOI: 10.1158/0008-5472.Fbcr09-A71 |
0.698 |
|
| Show low-probability matches. |